Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Eliglustat Tartrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 22,513Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cipla`s Generics Eliglustat Tartrate Receives Approval in US
    Cipla`s Generics Eliglustat Tartrate Receives Approval in US

    10 Dec 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212369

    FDA
    10 Dec 2024
    Share Share
    Zenara Pharma Generic Eliglustat Tartrate Receives Approval in the U.S
    Zenara Pharma Generic Eliglustat Tartrate Receives Approval in the U.S

    02 May 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212420

    FDA
    02 May 2023
    Share Share
    Dr. Reddy's Generic Eliglustat Tartrate Receives Approval in the U.S.
    Dr. Reddy's Generic Eliglustat Tartrate Receives Approval in the U.S.

    17 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212449

    FDA
    17 Aug 2022
    Share Share
    Aizant's Generic Eliglustat Tartrate Receives Approval in the US
    Aizant's Generic Eliglustat Tartrate Receives Approval in the US

    08 Sep 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212463

    FDA
    08 Sep 2021
    Share Share
    Cerdelga (eliglustat) : Genzyme vs. Apotex
    Cerdelga (eliglustat) : Genzyme vs. Apotex

    24 Nov 2018

    // PATENT LITIGATION

    https://insight.rpxcorp.com/litigation_documents/13142009

    PATENT LITIGATION
    24 Nov 2018
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Cerdelga (Eliglustat) Tablets
    FDA Confirms Paragraph IV Patent Challenge of Cerdelga (Eliglustat) Tablets

    16 Oct 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-cerdelga-eliglustat-tablets-1539771276.pdf

    FDA
    16 Oct 2018
    Share Share